Agree that it would be a good idea to contact Suzy Chapman
I have some concerns with this letter.
First, the letter states the following:
Many have been aware that the category of “somatoform disorders” is under revision in that draft[xiii]. This is the diagnosis in psychiatry for physical symptoms caused by mental distress, and it will be replaced in the general ICD by “bodily distress disorder”, or BDD (which is a lot like “somatic symptom disorder” in the most recent DSM). Criteria for BDD are not particularly problematic for ME patients. They are compatible with construing ME as a biological disease.
I disagree with the bolded statement and a similar statement elsewhere in the document. Terms like somatic symptom disorder, BDD and all the other terms that frame physical symptoms as a psychological condition are particularly problematic for people with ME because the disease is widely misunderstood and has a history of being conflated with these terms.
When the DSM-5 was under development, a broad cross-section of disease groups objected to the term "somatic symptom disorder" because its criteria were so broad - a patient can be given this diagnosis if the provider "feels" that the patient's concerns with their symptoms are "excessive." Even the chair of the DSM-4, Allen Francis, published articles about the problems with this construct. Here's one -
https://www.psychologytoday.com/us/...sm-5-refuses-correct-somatic-symptom-disorder
Beyond that, from discussions with Suzy Chapman, a) its not clear to me that WHO has actually made a decision on the BSS category or on proposals being floated by other groups b) its not clear which countries use this primary care version being discussed. I think it will be important to clarify both of these
Finally, this statement is quite bold but I'd want to see the evidence that WHO actually "intends" to route ME patients into psychiatry.
At this time it seems clear that the US health authorities driving the new biological approach to ME are unaware of the WHO’s intention to route ME patients across the globe into psychiatry through the ICD-11-PHC.
Some background regarding ICD-11 - There are two main proposals that I know of. Suzy and I submitted a proposal to ICD Revision last March to retain ME and CFS in the neurological chapter. A second proposal was submitted in November 2017 to move ME and CFS to the Symptoms chapter under symptoms of the musculoskeletal system because fatigue is "a manifestation of skeletal muscle dysfunction." This second proposal is remarkably flawed, ignored most of the biomedical evidence and instead relied heavily on the CBT/GET/Biopsychosocial studies.
WHO has stated that they are not going to make any decisions on these proposals until they complete an evidence review, which is due shortly. Suzy and I submitted a response to the second proposal that summarized its flaws and called on WHO to include the breadth of evidence assessed by IOM and in more recent studies.